Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Multiple Sclerosis in Children.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Analysis of oxidative stress in zebrafish embryos.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
The impact of multiple sclerosis on family members: a review of the literature.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Psychiatric symptoms in patients with multiple sclerosis.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

Pages